SMMT

Conviction 69HealthcareScan · Thu, Sep 24, 2026

Summit Therapeutics Inc. (SMMT) closed at $16.39 (-0.40%) on Sep 24, 2026. Price is above its 50-day and below its 200-day moving average. RSI(14) 52, RS Rating 49, -37.9% from its 52-week high, -6.5% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

SMMT$16.39-0.40%

ResistanceSupportVol 14Insider buy

Vol MA14 6.89M

Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24

Summit Therapeutics Inc.PHARMACEUTICAL PREPARATIONSwww.smmttx.com ↗

Price16.39

Change-0.40%

Gap-0.73%

Rel volume2.54×

Avg volume6.7M

Avg $ vol112.13M

SMA 2016.50

SMA 5014.78

SMA 20016.40

Price vs 50+10.86%

Price vs 200-0.09%

MA stackmixed

50/200 cross—

Supertrendup · 15.42

RSI (14)52

MACD hist-0.15

MACD crossbear · 1d

Stoch %K / %D11 / 34

ADX (14)24

+DI / −DI26 / 22

RSI divergence—

MACD divergence—

ATR %5.92%

ADR %5.43%

52w high26.38

52w low12.43

From 52w high-37.89%

Above 52w low+31.82%

New 52w highNo

SqueezeOff

Bollinger width35.71%

%B0.48

Donchian pos55.22%

Donchian high18.83

Donchian low13.37

AVWAP (52w high)15.84

vs AVWAP high+3.41%

AVWAP (52w low)15.67

vs AVWAP low+4.55%

OBV trendFlat

Chaikin MF (20)0.12

Today vs 20d2.54×

Avg vol (14d)6.89M

Avg vol (20d)6.7M

Avg $ vol (20d)112.13M

Market cap13.07B

RS Rating49 / 99

RS 3m (vs SPY)+11.06%

RS 6m (vs SPY)-25.49%

RS line new highNo

Trend template3/8

Technical rank57.2

1 week-7.53%

1 month+22.64%

3 months+15.55%

6 months-8.67%

1 year-14.44%

YTD-6.48%

P/E-12.11

P/B20.75

P/S—

P/FCF-40.39

EPS-1.44

Div yield—

ROE-171.37%

ROA-143.53%

Debt/Eq—

Current6.96

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-387.81%

Price target29.26

Target upside78.58%

Analyst ratingBuy

Institutional18.43%

Ent. value12.65B

Revenue0

Net income-215.7M

Gross profit—

Free cash flow-323.59M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out776.16M

Employees265

ListedThu, Mar 5, 2015

Free float134.57M

Float %17.3%

Short interest41.33M

Days to cover6.6d

Short volume60.7%

Squeeze score94 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.28 vs −$0.26

Last surprise-7.7% miss

Setup gradeB

Conviction69 / 100

Pattern quality—

Tech rank57.2 / 100

Group rank59 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance18.63

Support12.15

Days since event—

Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in SMMT

All disclosures →

No recent disclosed trades by Congress in SMMT. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in SMMT · open-market 3 buys

Insider	Side	Shares	Value	Traded	Filed
DUGGAN ROBERT W Co-Chief Executive Officer · Common Stock · 2026-06-04	Other	—	—	2026-06-04	2026-06-04
Soni Manmeet Singh COO and CFO · Common Stock · 2026-06-04	Buy	25K	$361K	2026-06-04	2026-06-04
Zanganeh Mahkam Co-Chief Executive Officer · Common Stock · 2026-06-04	Other	—	—	2026-06-04	2026-06-04
Zanganeh Mahkam Co-Chief Executive Officer · Common Stock · 2026-06-04	Buy	100K	$1.5M	2026-06-04	2026-06-04
DUGGAN ROBERT W Co-Chief Executive Officer · Common Stock · 2026-06-04	Buy	100K	$1.5M	2026-06-04	2026-06-04

SEC filings

EDGAR filings in SMMT · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.